News Feed Opinion Career Insight Dialogues Blog Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
July, 2024
July 2024
M T W T F S S
1234567
891011121314
15161718192021
22232425262728
293031  
Jerónimo Rafael Rodríguez Cid: A secondary analysis from MARIPOSA
Photo of Jerónimo Rafael Rodríguez Cid from Oncologia.mx
Jul 10, 2024, 09:39

Jerónimo Rafael Rodríguez Cid: A secondary analysis from MARIPOSA

Jerónimo Rafael Rodríguez Cid, Medical Oncologist at CDMX shared a post on X:

“We published this analysis of the Mariposa trial that shows the influence of p53 gene in patients with EGFR genetic alteration lung cancer treated with amivantamab versus osimertinib. We will never stop trying/Nunca dejaremos de intentarlo.”

Jerónimo Rafael Rodríguez

Read the article.

Source: Jerónimo Rafael Rodríguez Cid/X

cancer CDMX EGFR Jerónimo Rafael Rodríguez Cid Lung cancer OncoDaily Oncology p53 gene
Blog
Jul 28, 2024, 02:24
Cancer Discovery Hub - Comprehensive review paper on Angiosarcoma - an Asian-prevalent rare cancer
Blog
Jul 28, 2024, 02:14
European Cancer Organisation - Enhance your cancer care training with INTERACTEUROPE100
Blog
Jul 28, 2024, 01:59
Improving community engagement and equity at the ACCC 41st National Oncology Conference
Blog
Jul 27, 2024, 23:04
Fight Colorectal Cancer - Timothy Yen launched a pilot program to enhance provider-patient communication about familial CRC
Blog
Jul 27, 2024, 23:04
Abhijit Pal: Medical oncology trials fellow funding available at Liverpool Hospital for 2025
Blog
Jul 27, 2024, 23:04
Fumiko Ladd Chino: Financial Toxicity is not one size fits all
Blog
Jul 27, 2024, 23:04
The US Oncology Network - The importance of Social Drivers of Health and a more equitable healthcare system
Blog
Jul 27, 2024, 23:04
Herbert Loong: Daniel Goldstein shares insights and experiences in pharmacoeconomics
Blog
Jul 27, 2024, 23:04
Kimryn Rathmell: I had the honor of speaking at the 6th annual Glioblastoma Awareness Day reception hosted by National Brain Tumor Society
Blog
Jul 27, 2024, 23:04
LUNGevity Foundation and Oncogene Cancer Research are joining up with 23andMe to advance lung cancer research
Insight
Jul 27, 2024, 22:17
A blood test that may predict if people with relapsed MM are going to respond well to CAR-T immunotherapy - Weill Cornell Medicine
Insight
Jul 27, 2024, 22:17
Commentary led by Marleen Kok highlights all questions in early TNBC post-KN522